Our Science

First-In-Class 면역항암제 개발 기업 넥스아이

Pipeline

Project Target Indication Target market
position
Partner Discovery Candidate
optimization
Pre-clinical Phase I/II
NXI-101
ONCOKINE-1
Solid Cancer
FIC
NXI-201
ONCOKINE-2
Solid Cancer
(Melanoma, CRC, etc.)
FIC
NXI-301
ONCOKINE-3
Solid Cancer
FIC
NXI-M01
Myeloid cells
Solid Cancer
FIC
NXI-C01
Undisclosed
Solid Cancer
FIC

*FIC : First-In-Class / *NSCLC : Non small cell lung cancer / *TNBC : Triple negative breast cancer / *CRC : Colorectal cancer